glp-1 optimization consultation maryland Optimizing therapies for obesity and diabetes management GLP-1 medications may not work
Description
Studies show 2540% of GLP-1 users experience abdominal distension, making symptom management a priority for treatment adherence and quality of life
Alcohol misuse remains a recognized risk in chronic pain populations
Baig et al
Glenmark GLIPIQ vials start at 325/week (~1,300/month)
doi: 10.3904/kjim.2019.109
Highlights of Prescribing Information
